Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Atai Beckley Inc. (ATAI)
USD4.97
-0.20 (-3.87%)
US NASDAQ Healthcare Biotechnology
Address
250 West 34th Street 10119
New York, NY, US
New York, NY, US
CEO
Christian Angermayer
Website
ataibeckley.com
IPO
2021-06-18
CIK 1840904 ISIN US04650F1012
Description
Atai Beckley Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the discovery, advancement, and commercialization of innovative therapeutic solutions for a variety of mental health conditions. The company's operations extend across the United States, Germany, and Canada. Its development pipeline features several key compounds: BPL-003: An intranasally administered formulation of mebufotenin benzoate salt, currently undergoing Phase 2a and 2b clinical trials for its potential in treating both treatment-resistant depression (TRD) and alcohol use disorder. RL-007: An orally active, pro-cognitive neuromodulator, progressing through a Phase 2b study focused on cognitive impairment associated with schizophrenia. ELE-101: A serotonergic psychedelic compound designed to address major depressive disorder. VLS-01: An oral transmucosal film featuring N,N-Dimethyltryptamine, which is in a Phase 2 clinical study for TRD. EMP-01: An orally administered form of R-3,4-methylenedioxy-methamphetamine, also in Phase 2 trials for social anxiety disorder. EGX-A & EGX-B: Non-hallucinogenic 5-HT2A receptor agonists, which are being explored for treatment-resistant depression. Beyond these pipeline assets, the firm also provides COMP360 for psilocybin therapy and GRX-917, aimed at treating anxiety, depression, and various neurological conditions. Originally known as Atai Beckley N.V., the entity officially changed its name to Atai Beckley Inc. in December 2025. Established in 2018, its corporate headquarters are situated in New York, New York.
News Sentiment (7d)
10 articles
- FuelCell Energy shares fall after company prices upsized $225M stock offering Proactive Investors - Finance
- AtaiBeckley set to unlock value from positive depression therapy trial results, says Jefferies Proactive Investors
- AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder GlobeNewsWire
- What This $496,000 Insider Sale at AtaiBeckley Means Amid Roughly 100% Stock Run The Motley Fool
- AtaiBeckley Completes VLS-01 Dosing in Phase IIb Depression Study Zacks Investment Research
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.97
-0.20 (-3.87%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
7M
Beta
1.61
Float Shares
102.49M
Free Float %
54.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.17% | +5.21% | +11.87% | +18.77% | +2.66% | +3.67% | +200.71% | +112.00% | -78.68% | -78.68% | -78.68% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
4.97
Low
10.00
+101.2%
Consensus
12.00
+141.4%
Median
11.50
+131.4%
High
15.00
+201.8%
DCF (Unlevered)
0.18
-96.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 12 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
15.00
+201.8%
|
| Last Quarter | 3 |
12.33
+148.1%
|
| Last Year | 7 |
11.29
+127.2%
|
| All Time | 8 |
10.63
+113.9%
|
Quality scores
Altman Z-Score
0.02
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+1,227.6% ★ Q1'26: -38.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%-212.9% Q1'26: +44.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-16,300.1% Q1'26: -5,058.1% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-16,108.8% Q1'26: -3,239.1% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +412.2% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+41.4% Q1'26: +102.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 8 EPS Ana. |
Dec 2027 6 Rev. Ana. 8 EPS Ana. |
Dec 2028 9 Rev. Ana. 11 EPS Ana. |
Dec 2029 4 Rev. Ana. 4 EPS Ana. |
Dec 2030 4 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
20.38M
est: 20.09M (+1.4%)
|
233.0K
est: 176.5K (+32.0%)
|
314.0K
est: 378.0K (-16.9%)
|
308.0K
est: 518.0K (-40.5%)
|
4.09M
est: 3.01M (+36.1%)
|
950.9K
950.9K – 950.9K
-68.4% YoY
|
330.0K
330.0K – 330.0K
-65.3% YoY
|
10.24M
10.24M – 10.24M
+3,002.3% YoY
|
126.77M
126.77M – 126.77M
+1,138.3% YoY
|
377.02M
377.02M – 377.02M
+197.4% YoY
|
| EBITDA |
-120.28M
est: -12.06M (-897.6%)
|
-134.09M
est: -105.9K (-126,547.9%)
|
-36.31M
est: -378.0K (-9,506.1%)
|
-144.81M
est: -518.0K (-27,855.2%)
|
-657.68M
est: -3.01M (-21,783.8%)
|
-950.9K
-950.9K – -950.9K
+68.4% YoY
|
-330.0K
-330.0K – -330.0K
+65.3% YoY
|
-10.24M
-10.24M – -10.24M
-3,002.3% YoY
|
-126.77M
-126.77M – -126.77M
-1,138.3% YoY
|
-377.02M
-377.02M – -377.02M
-197.4% YoY
|
| EBIT |
-120.33M
est: -12.06M (-898.0%)
|
-134.26M
est: -105.9K (-126,706.6%)
|
-36.63M
est: -378.0K (-9,590.5%)
|
-145.28M
est: -518.0K (-27,946.5%)
|
-658.69M
est: -3.01M (-21,817.5%)
|
-950.9K
-950.9K – -950.9K
+68.4% YoY
|
-330.0K
-330.0K – -330.0K
+65.3% YoY
|
-10.24M
-10.24M – -10.24M
-3,002.3% YoY
|
-126.77M
-126.77M – -126.77M
-1,138.3% YoY
|
-377.02M
-377.02M – -377.02M
-197.4% YoY
|
| Net Income |
-167.81M
est: -133.45M (-25.7%)
|
-152.39M
est: -145.08M (-5.0%)
|
-40.22M
est: -81.83M (+50.8%)
|
-149.27M
est: -173.35M (+13.9%)
|
-660.05M
est: -137.65M (-379.5%)
|
-140.26M
-172.62M – -85.19M
-1.9% YoY
|
-128.52M
-166.32M – -90.72M
+8.4% YoY
|
-128.05M
-174.51M – -81.59M
+0.4% YoY
|
-76.37M
-76.37M – -76.37M
+40.4% YoY
|
35.30M
35.30M – 35.30M
+146.2% YoY
|
| SGA |
92.75M
est: 2.67B (-96.5%)
|
70.35M
est: 23.45M (+200.1%)
|
63.58M
est: 51.35M (+23.8%)
|
47.54M
est: 70.37M (-32.4%)
|
65.09M
est: 408.27M (-84.1%)
|
129.18M
129.18M – 129.18M
-68.4% YoY
|
44.83M
44.83M – 44.83M
-65.3% YoY
|
1.39B
1.39B – 1.39B
+3,002.3% YoY
|
17.22B
17.22B – 17.22B
+1,138.3% YoY
|
51.22B
51.22B – 51.22B
+197.4% YoY
|
| EPS |
-1.04
est: -0.83 (-24.8%)
|
-0.98
est: -0.91 (-7.9%)
|
-0.25
est: -0.36 (+30.8%)
|
-0.93
est: -0.81 (-15.2%)
|
-2.91
est: -0.62 (-368.2%)
|
-0.48
-0.76 – -0.38
+23.6% YoY
|
-0.49
-0.73 – -0.40
-2.4% YoY
|
-0.51
-0.77 – -0.36
-3.9% YoY
|
-0.34
-0.34 – -0.34
+33.3% YoY
|
0.16
0.16 – 0.16
+146.2% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-20 | Canaccord Genuity | Buy | Buy | Maintain |
| 2026-04-17 | Guggenheim | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-112.62M
OE per share TTM
-0.54
Owner's Yield
-7.43%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
45.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
77
Total invested
106.59M
Insider transactions (90d)
0
Beneficial owners (>5%)
12
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ATAI Life Sciences B.V. | 233.68M | 67.60% | — | 233.68M | — | 11.00 | CO | — | 2021-05-24 | ↗ |
| 2 | Apeiron Investment Group Ltd. | 32.06M | 19.70% | — | 32.06M | — | 32.06M | CO | — | 2022-02-10 | ↗ |
| 3 | Christian Angermayer | 32.06M | 19.70% | — | 32.06M | — | 32.06M | IN | — | 2022-02-10 | ↗ |
| 4 | E. Novogratz | 10.80M | 6.70% | — | 10.80M | — | 10.80M | IN | Delaware | 2022-03-01 | ↗ |
| 5 | Group Funding (ECI) (U) LLC | 10.80M | 6.70% | — | 10.80M | — | 10.80M | OO | Delaware | 2022-03-01 | ↗ |
| 6 | Group Investments LLC | 10.80M | 6.70% | — | 10.80M | — | 10.80M | OO | Delaware | 2022-03-01 | ↗ |
| 7 | ATAI Life Sciences BV | 8.08M | 19.70% | — | 8.08M | — | 8.08M | CO | — | 2021-05-24 | ↗ |
| 8 | ATAI Life Sciences AG | 6.91M | 10.10% | — | 6.91M | — | 6.91M | CO | — | 2024-09-27 | ↗ |
| 9 | ATAI Life Sciences N.V. | 6.91M | 10.10% | — | 6.91M | — | 6.91M | CO | — | 2024-09-27 | ↗ |
| 10 | Apeiron Presight Capital Fund II, L.P. | 1.19M | 0.70% | — | 1.19M | — | 1.19M | PN | — | 2022-02-10 | ↗ |
| 11 | Fabian Hansen | 1.19M | 0.70% | — | 1.19M | — | 1.19M | IN | — | 2022-02-10 | ↗ |
| 12 | Presight Capital Management I, L.L.C. | 1.19M | 0.70% | — | 1.19M | — | 1.19M | OO | — | 2022-02-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
77
-48 vs prev Q
New positions
39
Closed positions
83
Increased
49
Reduced
9
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 7.08M +1.6M (+30.3%) | 28.96M +206.6K (+0.7%) | 3.25% +0.489 pp | 0.04% -0.002 pp | USD2.63 +55.5% | 3 qtrs — |
| 2 | MORGAN STANLEY | 4.82M +5.4K (+0.1%) | 19.72M -5.8M (-22.6%) | 2.22% -0.234 pp | 0.00% 0.000 pp | USD5.99 -31.7% | 19 qtrs — |
| 3 | DEEP TRACK CAPITAL, LP | 4.68M +4.7M (+100.0%) | 19.13M +19.1M (+100.0%) | 2.15% +2.150 pp | 0.34% +0.341 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 4 | BLACKROCK, INC. | 2.81M +2.8M (+63,836.5%) | 11.51M +11.5M (+49,333.0%) | 1.29% +1.291 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 6 qtrs — |
| 5 | FORESITE CAPITAL MANAGEMENT VI LLC | 2.75M +2.8M (+100.0%) | 11.25M +11.2M (+100.0%) | 1.26% +1.264 pp | 3.40% +3.400 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 6 | RTW INVESTMENTS, LP | 2.00M +2.0M (+100.0%) | 8.18M +8.2M (+100.0%) | 0.92% +0.919 pp | 0.08% +0.082 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 7 | AMERIPRISE FINANCIAL INC | 1.74M +1.7M (+100.0%) | 7.10M +7.1M (+100.0%) | 0.80% +0.797 pp | 0.00% +0.002 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 8 | ALLY BRIDGE GROUP (NY) LLC | 1.71M -573.9K (-25.1%) | 7.01M -5.1M (-42.1%) | 0.79% -0.376 pp | 7.30% -0.068 pp | USD5.29 -22.7% | 2 qtrs — |
| 9 | EAGLE HEALTH INVESTMENTS LP | 1.68M +1.7M (+100.0%) | 6.86M +6.9M (+100.0%) | 0.77% +0.771 pp | 1.51% +1.509 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 10 | HRT FINANCIAL LP | 1.47M +1.1M (+266.1%) | 6.01M +3.9M (+183.2%) | 0.68% +0.471 pp | 0.02% +0.011 pp | USD4.42 -7.5% | 2 qtrs — |
| 11 | TWO SIGMA INVESTMENTS, LP | 1.41M +1.0M (+287.6%) | 5.77M +3.8M (+199.7%) | 0.65% +0.463 pp | 0.01% +0.005 pp | USD3.73 +9.7% | 17 qtrs — |
| 12 | QUBE RESEARCH & TECHNOLOGIES LTD | 1.28M +1.2M (+1,733.3%) | 5.24M +4.9M (+1,317.4%) | 0.59% +0.553 pp | 0.01% +0.005 pp | USD4.16 -1.7% | 2 qtrs — |
| 13 | POINT72 ASSET MANAGEMENT, L.P. | 935.7K +935.7K (+100.0%) | 3.83M +3.8M (+100.0%) | 0.43% +0.430 pp | 0.00% +0.004 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 14 | GOLDMAN SACHS GROUP INC | 930.0K +481.0K (+107.1%) | 3.80M +1.4M (+60.1%) | 0.43% +0.199 pp | 0.00% +0.000 pp | USD3.55 +15.2% | 17 qtrs — |
| 15 | ADAR1 CAPITAL MANAGEMENT, LLC | 913.2K +— (+0.0%) | 3.74M -1.1M (-22.7%) | 0.42% -0.045 pp | 0.27% -0.180 pp | USD5.29 -22.7% | 2 qtrs — |
| 16 | CENTERBOOK PARTNERS LP | 780.5K +129.4K (+19.9%) | 3.19M -252.2K (-7.3%) | 0.36% +0.027 pp | 0.16% -0.014 pp | USD5.09 -19.6% | 2 qtrs — |
| 17 | JANE STREET GROUP, LLC | 760.0K +162.7K (+27.2%) | 3.11M -51.2K (-1.6%) | 0.35% +0.045 pp | 0.00% +0.000 pp | USD4.60 -11.1% | 17 qtrs — |
| 18 | BROWN UNIVERSITY | 718.5K +— (+0.0%) | 2.94M -862.2K (-22.7%) | 0.33% -0.035 pp | 2.06% -0.187 pp | USD12.48 -67.2% | 19 qtrs — |
| 19 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 607.5K +157.7K (+35.0%) | 2.48M +105.1K (+4.4%) | 0.28% +0.050 pp | 0.00% +0.000 pp | USD4.98 -17.9% | 2 qtrs — |
| 20 | WOODLINE PARTNERS LP | 600.0K +600.0K (+100.0%) | 2.45M +2.5M (+100.0%) | 0.28% +0.276 pp | 0.01% +0.010 pp | USD4.09 +0.0% | 6 qtrs — |
| 21 | PEAK6 LLC | 586.0K -42.6K (-6.8%) | 2.40M -928.6K (-27.9%) | 0.27% -0.051 pp | 0.00% 0.000 pp | USD5.29 -22.7% | 4 qtrs — |
| 22 | ADVISORSHARES INVESTMENTS LLC | 548.6K +42.3K (+8.4%) | 2.24M -434.6K (-16.2%) | 0.25% -0.006 pp | 0.37% -0.063 pp | USD3.33 +22.8% | 18 qtrs — |
| 23 | SQUAREPOINT OPS LLC | 354.7K +203.0K (+133.9%) | 1.45M +648.4K (+80.8%) | 0.16% +0.086 pp | 0.00% +0.001 pp | USD4.60 -11.1% | 2 qtrs — |
| 24 | SWISS NATIONAL BANK | 325.9K +325.9K (+100.0%) | 1.33M +1.3M (+100.0%) | 0.15% +0.150 pp | 0.00% +0.001 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 25 | GROUP ONE TRADING, L.P. | 321.3K -279.2K (-46.5%) | 1.31M -1.9M (-58.6%) | 0.15% -0.158 pp | 0.00% -0.003 pp | USD5.04 -18.8% | 6 qtrs — |
| 26 | JPMORGAN CHASE & CO | 297.0K -472.6K (-61.4%) | 1.21M -2.9M (-70.2%) | 0.14% -0.255 pp | 0.00% 0.000 pp | USD5.22 -21.6% | 17 qtrs — |
| 27 | STABLEFORD CAPITAL II LLC | 291.6K +291.6K (+100.0%) | 1.19M +1.2M (+100.0%) | 0.13% +0.134 pp | 0.43% +0.431 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 28 | STATE STREET CORP | 288.3K +145.8K (+102.2%) | 1.18M +425.1K (+56.4%) | 0.13% +0.060 pp | 0.00% +0.000 pp | USD3.92 +4.3% | 17 qtrs — |
| 29 | AMERICAN CENTURY COMPANIES INC | 270.5K +22.6K (+9.1%) | 1.11M -205.1K (-15.6%) | 0.12% -0.002 pp | 0.00% 0.000 pp | USD5.19 -21.2% | 4 qtrs — |
| 30 | D. E. SHAW & CO., INC. | 264.5K -447.9K (-62.9%) | 1.08M -2.7M (-71.3%) | 0.12% -0.241 pp | 0.00% -0.002 pp | USD1.46 +180.1% | 5 qtrs — |
| 31 | MAN GROUP PLC | 238.8K +206.5K (+639.7%) | 976.5K +805.7K (+471.9%) | 0.11% +0.093 pp | 0.00% +0.001 pp | USD4.25 -3.8% | 2 qtrs — |
| 32 | BRUMMER MULTI-STRATEGY AB | 234.9K +234.9K (+100.0%) | 960.8K +960.8K (+100.0%) | 0.11% +0.108 pp | 5.81% +5.808 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 33 | CITADEL ADVISORS LLC | 215.9K +34.5K (+19.0%) | 883.0K -76.6K (-8.0%) | 0.10% +0.007 pp | 0.00% +0.000 pp | USD4.38 -6.6% | 18 qtrs — |
| 34 | CATALIO CAPITAL MANAGEMENT, LP | 196.9K +— (+0.0%) | 805.1K -236.2K (-22.7%) | 0.09% -0.010 pp | 0.14% -0.050 pp | USD1.33 +207.5% | 5 qtrs — |
| 35 | SHAY CAPITAL LLC | 195.0K +127.0K (+186.8%) | 797.6K +437.8K (+121.7%) | 0.09% +0.055 pp | 0.08% +0.051 pp | USD4.51 -9.3% | 4 qtrs — |
| 36 | UBS ASSET MANAGEMENT AMERICAS INC | 189.5K +189.5K (+100.0%) | 775.1K +775.1K (+100.0%) | 0.09% +0.087 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 37 | BURKEHILL GLOBAL MANAGEMENT, LP | 185.0K +185.0K (+100.0%) | 756.7K +756.7K (+100.0%) | 0.09% +0.085 pp | 0.05% +0.050 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 38 | NUVEEN, LLC | 180.0K +180.0K (+100.0%) | 736.1K +736.1K (+100.0%) | 0.08% +0.083 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 39 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 179.0K +— (+0.0%) | 732.1K -214.8K (-22.7%) | 0.08% -0.009 pp | 0.00% -0.001 pp | USD5.29 -22.7% | 2 qtrs — |
| 40 | TWO SIGMA ADVISERS, LP | 176.2K +176.2K (+100.0%) | 720.7K +720.7K (+100.0%) | 0.08% +0.081 pp | 0.00% +0.001 pp | USD4.09 +0.0% | 17 qtrs — |
| 41 | VANGUARD GROUP INC | 153.6K -290.4K (-65.4%) | 628.2K -1.7M (-73.3%) | 0.07% -0.155 pp | 0.00% +0.000 pp | USD3.37 +21.4% | 15 qtrs — |
| 42 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 151.5K +151.5K (+100.0%) | 619.4K +619.4K (+100.0%) | 0.07% +0.070 pp | 0.00% +0.001 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 43 | XTX TOPCO LTD | 130.5K +130.5K (+100.0%) | 533.7K +533.7K (+100.0%) | 0.06% +0.060 pp | 0.01% +0.014 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 44 | LEGAL & GENERAL GROUP PLC | 127.5K +127.5K (+100.0%) | 521.7K +521.7K (+100.0%) | 0.06% +0.059 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 45 | NORTHERN TRUST CORP | 124.1K +124.1K (+100.0%) | 507.4K +507.4K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 46 | IQ EQ FUND MANAGEMENT (IRELAND) LTD | 121.4K +69.0K (+131.7%) | 496.6K +219.5K (+79.2%) | 0.06% +0.029 pp | 0.03% +0.016 pp | USD4.61 -11.3% | 2 qtrs — |
| 47 | BARCLAYS PLC | 115.9K -130.6K (-53.0%) | 474.2K +188.2K (+65.8%) | 0.05% -0.072 pp | 0.00% +0.000 pp | USD3.35 +22.1% | 15 qtrs — |
| 48 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 84.2K +84.2K (+100.0%) | 344.6K +344.6K (+100.0%) | 0.04% +0.039 pp | 0.00% +0.001 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 49 | NOMURA HOLDINGS INC | 83.9K +83.9K (+100.0%) | 343.2K +343.2K (+100.0%) | 0.04% +0.039 pp | 0.00% +0.001 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 50 | BANK OF AMERICA CORP /DE/ | 74.5K -153.7K (-67.3%) | 304.9K -902.8K (-74.8%) | 0.03% -0.082 pp | 0.00% 0.000 pp | USD3.55 +15.2% | 19 qtrs — |
| 51 | KLP KAPITALFORVALTNING AS | 69.8K +69.8K (+100.0%) | 285.5K +285.5K (+100.0%) | 0.03% +0.032 pp | 0.00% +0.001 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 52 | CARRERA CAPITAL ADVISORS | 66.8K +66.8K (+100.0%) | 273.3K +273.3K (+100.0%) | 0.03% +0.031 pp | 0.05% +0.046 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 53 | QUANTINNO CAPITAL MANAGEMENT LP | 58.2K +— (+0.0%) | 238.2K -69.9K (-22.7%) | 0.03% -0.003 pp | 0.00% 0.000 pp | USD2.19 +86.8% | 3 qtrs — |
| 54 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 57.2K -52.6K (-47.9%) | 228.9K -379.3K (-62.4%) | 0.03% -0.030 pp | 0.00% -0.001 pp | USD5.29 -22.7% | 2 qtrs — |
| 55 | SIMPLEX TRADING, LLC | 53.1K -84.6K (-61.4%) | 217.0K -511.0K (-70.2%) | 0.02% -0.046 pp | 0.00% 0.000 pp | USD3.50 +16.9% | 9 qtrs — |
| 56 | CAPROCK GROUP, LLC | 52.1K +52.1K (+100.0%) | 213.0K +213.0K (+100.0%) | 0.02% +0.024 pp | 0.00% +0.005 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 57 | SEAVIEW INVESTMENT MANAGERS LLC | 49.9K +— (+0.0%) | 204.2K -59.9K (-22.7%) | 0.02% -0.003 pp | 0.08% -0.021 pp | USD1.33 +207.5% | 16 qtrs — |
| 58 | STEPHENS INC /AR/ | 47.0K +17.6K (+59.9%) | 192.1K +36.7K (+23.6%) | 0.02% +0.007 pp | 0.00% +0.000 pp | USD4.84 -15.5% | 2 qtrs — |
| 59 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 46.4K +46.4K (+100.0%) | 189.7K +189.7K (+100.0%) | 0.02% +0.021 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 60 | ARIZONA STATE RETIREMENT SYSTEM | 46.1K +46.1K (+100.0%) | 188.4K +188.4K (+100.0%) | 0.02% +0.021 pp | 0.00% +0.001 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 61 | PALE FIRE CAPITAL SE | 45.8K -1.0M (-95.8%) | 187.4K -5.5M (-96.7%) | 0.02% -0.529 pp | 0.01% -0.613 pp | USD1.37 +198.5% | 7 qtrs — |
| 62 | PERSISTENT ASSET PARTNERS LTD | 44.0K +44.0K (+100.0%) | 179.9K +179.9K (+100.0%) | 0.02% +0.020 pp | 0.08% +0.081 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 63 | CRESSET ASSET MANAGEMENT, LLC | 36.0K +— (+0.0%) | 147.2K -43.2K (-22.7%) | 0.02% -0.002 pp | 0.00% 0.000 pp | USD1.55 +163.9% | 17 qtrs — |
| 64 | RAYMOND JAMES FINANCIAL INC | 31.3K -45.4K (-59.1%) | 128.2K -277.5K (-68.4%) | 0.01% -0.025 pp | 0.00% 0.000 pp | USD2.63 +55.5% | 5 qtrs — |
| 65 | KINGSWOOD WEALTH ADVISORS, LLC | 30.0K -10.0K (-25.0%) | 122.7K -88.9K (-42.0%) | 0.01% -0.007 pp | 0.01% -0.007 pp | USD1.34 +205.2% | 5 qtrs — |
| 66 | BALYASNY ASSET MANAGEMENT L.P. | 29.0K -89.9K (-75.6%) | 118.4K -510.4K (-81.2%) | 0.01% -0.047 pp | 0.00% -0.001 pp | USD5.29 -22.7% | 2 qtrs — |
| 67 | ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 28.3K +11.6K (+69.6%) | 115.7K +27.5K (+31.1%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD3.25 +25.8% | 13 qtrs — |
| 68 | EVOKE WEALTH, LLC | 26.6K +— (+0.0%) | 108.8K -31.9K (-22.7%) | 0.01% -0.001 pp | 0.00% -0.001 pp | USD2.19 +86.8% | 3 qtrs — |
| 69 | JAIN GLOBAL LLC | 26.4K +26.4K (+100.0%) | 108.1K +108.1K (+100.0%) | 0.01% +0.012 pp | 0.00% +0.001 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 70 | CREATIVE PLANNING | 25.8K +— (+0.0%) | 105.4K -30.9K (-22.7%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD3.46 +18.2% | 16 qtrs — |
| 71 | BRIGHT FUTURES WEALTH MANAGEMENT, LLC. | 25.0K +— (+0.0%) | 102.3K -30.0K (-22.7%) | 0.01% -0.001 pp | 0.08% -0.028 pp | USD5.29 -22.7% | 2 qtrs — |
| 72 | TEACHER RETIREMENT SYSTEM OF TEXAS | 24.5K +24.5K (+100.0%) | 100.4K +100.4K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 73 | WEDMONT PRIVATE CAPITAL | 25.0K +— (+0.0%) | 100.0K -38.5K (-27.8%) | 0.01% -0.001 pp | 0.00% -0.002 pp | USD1.34 +205.2% | 7 qtrs — |
| 74 | LPL FINANCIAL LLC | 23.5K +1.7K (+7.9%) | 96.2K -19.1K (-16.5%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD2.31 +77.1% | 8 qtrs — |
| 75 | PICTET ASSET MANAGEMENT HOLDING SA | 22.3K +22.3K (+100.0%) | 91.0K +91.0K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 76 | IEQ CAPITAL, LLC | 21.9K +— (+0.0%) | 89.5K -26.3K (-22.7%) | 0.01% -0.001 pp | 0.00% 0.000 pp | USD5.29 -22.7% | 2 qtrs — |
| 77 | CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 20.6K +6.6K (+46.9%) | 84.0K +10.0K (+13.5%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD2.34 +74.8% | 7 qtrs — |
| 78 | MCADAM, LLC | 19.6K +19.6K (+100.0%) | 80.4K +80.4K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.004 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 79 | JANNEY MONTGOMERY SCOTT LLC | 19.5K +19.5K (+100.0%) | 80.0K +80.0K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 80 | INVESCO LTD. | 19.3K +9.3K (+92.8%) | 79.1K +26.1K (+49.1%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD3.10 +31.9% | 3 qtrs — |
| 81 | VERDENCE CAPITAL ADVISORS LLC | 19.2K +— (+0.0%) | 78.4K -40.8K (-34.2%) | 0.01% -0.001 pp | 0.00% -0.002 pp | USD5.08 -19.5% | 16 qtrs — |
| 82 | BAKER AVENUE ASSET MANAGEMENT, LP | 18.4K +— (+0.0%) | 75.3K -22.1K (-22.7%) | 0.01% -0.001 pp | 0.00% -0.001 pp | USD5.29 -22.7% | 2 qtrs — |
| 83 | VICTORY FINANCIAL GROUP, LLC | 18.3K +6.5K (+54.8%) | 75.0K +12.4K (+19.7%) | 0.01% +0.002 pp | 0.01% +0.001 pp | USD4.86 -15.8% | 2 qtrs — |
| 84 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 17.6K +17.6K (+100.0%) | 72.2K +72.2K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 85 | AUDENT GLOBAL ASSET MANAGEMENT, LLC | 16.8K +— (+0.0%) | 68.9K -20.2K (-22.7%) | 0.01% -0.001 pp | 0.04% -0.021 pp | USD7.63 -46.4% | 17 qtrs — |
| 86 | MIRACLE MILE ADVISORS, LLC | 16.8K +16.8K (+100.0%) | 68.9K +68.9K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.001 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 87 | RESOLUTE ADVISORS LLC | 16.8K +— (+0.0%) | 68.6K -20.1K (-22.7%) | 0.01% -0.001 pp | 0.02% 0.000 pp | USD2.19 +86.8% | 13 qtrs — |
| 88 | TRUIST FINANCIAL CORP | 16.4K +— (+0.0%) | 67.1K -19.7K (-22.7%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.96 +38.2% | 3 qtrs — |
| 89 | PROSHARE ADVISORS LLC | 16.0K +16.0K (+100.0%) | 65.6K +65.6K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 90 | NEUBERGER BERMAN GROUP LLC | 14.8K +2.2K (+17.6%) | 60.6K -6.1K (-9.1%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.87 +42.5% | 3 qtrs — |
| 91 | PTM WEALTH MANAGEMENT, LLC | 15.0K +— (+0.0%) | 58.1K -24.0K (-29.3%) | 0.01% -0.001 pp | 0.03% -0.016 pp | USD2.71 +50.9% | 3 qtrs — |
| 92 | CRA FINANCIAL SERVICES, LLC | 12.9K +— (+0.0%) | 52.8K -15.5K (-22.7%) | 0.01% -0.001 pp | 0.01% -0.002 pp | USD1.86 +119.9% | 8 qtrs — |
| 93 | HUNTER PERKINS CAPITAL MANAGEMENT, LLC | 12.3K -2.4K (-16.3%) | 50.0K -28.0K (-35.9%) | 0.01% -0.002 pp | 0.01% -0.006 pp | USD1.29 +217.1% | 16 qtrs — |
| 94 | COASTAL BRIDGE ADVISORS, LLC | 12.2K -2.4K (-16.2%) | 49.7K -27.0K (-35.2%) | 0.01% -0.002 pp | 0.00% -0.002 pp | USD5.29 -22.7% | 2 qtrs — |
| 95 | TUDOR INVESTMENT CORP ET AL | 11.7K +11.7K (+100.0%) | 47.7K +47.7K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.000 pp | USD4.09 +0.0% | 1 qtrs NEW |
| 96 | CITIGROUP INC | 11.1K -53.1K (-82.7%) | 45.3K -294.2K (-86.7%) | 0.01% -0.028 pp | 0.00% 0.000 pp | USD5.00 -18.2% | 18 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
10.00
Bullish
Ratio by volume
3.00
Bullish
Buys
10
Sells
1
Shares acquired
8.81M
Shares disposed
40.4K
Cash buys
—
Cash sales
—
Net activity
+8,766,929
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-25 | Feilding-Mellen Cosmo | Director | A-Award | A | Stock Option | 10,000 | 4.48 | 44.8K | 10,000 | D | ↗ |
| 2025-11-05 | HERSHBERG ROBERT | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-11-05 | Feilding-Mellen Cosmo | Director | A-Award | A | Common Shares | 7,702,990 | 0.00 | — | 7,702,990 | D | ↗ |
| 2025-11-04 | Braunstein Scott | Director | A-Award | A | Stock Option | 56,818 | 5.28 | 300.0K | 56,818 | D | ↗ |
| 2025-10-01 | Barrett Christopher Ryan Cave | Officer | — | — | Stock Option | 757,915 | 1.50 | 1.14M | 0 | D | ↗ |
| 2025-09-30 | Apeiron Investment Group Ltd. | 10% Owner | C-Conversion | D | Convertible Notes | 147,950 | 0.00 | — | 0 | I | ↗ |
| 2025-08-14 | Apeiron Investment Group Ltd. | 10% Owner | P-Purchase | A | Common Shares | 8,675,799 | 2.19 | 19.00M | 51,045,214 | I | ↗ |
| 2025-08-13 | Rao Srinivas | Officer | A-Award | A | Stock Option | 650,794 | 5.68 | 3.70M | 650,794 | D | ↗ |
| 2025-06-26 | Smiley Andrea Heslin | Director | A-Award | A | Stock Option | 103,000 | 2.25 | 231.8K | 103,000 | D | ↗ |
| 2025-06-26 | Kalali Amir H | Director | A-Award | A | Stock Option | 103,000 | 2.25 | 231.8K | 103,000 | D | ↗ |
| 2025-06-26 | JOHNSON SABRINA MARTUCCI | Director | A-Award | A | Stock Option | 103,000 | 2.25 | 231.8K | 103,000 | D | ↗ |
| 2025-06-26 | Hoffman John Francis | Director | A-Award | A | Stock Option | 206,000 | 2.25 | 463.5K | 206,000 | D | ↗ |
| 2025-06-26 | Fischer Laurent | Director | A-Award | A | Stock Option | 103,000 | 2.25 | 231.8K | 103,000 | D | ↗ |
| 2025-06-26 | Braunstein Scott | Director | A-Award | A | Stock Option | 103,000 | 2.25 | 231.8K | 103,000 | D | ↗ |
| 2025-06-26 | Angermayer Christian | Director / 10% Owner | A-Award | A | Stock Option | 103,000 | 2.25 | 231.8K | 103,000 | D | ↗ |
| 2025-06-02 | Angermayer Christian | Director / 10% Owner | A-Award | A | Stock Option | 131,698 | 2.49 | 327.9K | 131,698 | D | ↗ |
| 2025-05-15 | Hoffman John Francis | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-03-24 | Apeiron Investment Group Ltd. | 10% Owner | P-Purchase | A | Common Shares | 1,800,000 | 1.40 | 2.52M | 42,369,415 | I | ↗ |
| 2025-03-21 | Short Glenn Frank | Officer | S-Sale | D | Common Shares | 13,161 | 1.35 | 17.8K | 42,333 | D | ↗ |
| 2025-03-21 | Rao Srinivas | Officer | S-Sale | D | Common Shares | 75,418 | 1.35 | 101.8K | 212,942 | D | ↗ |
| 2025-03-21 | Kirpekar Sahil | Officer | S-Sale | D | Common Shares | 48,563 | 1.35 | 65.6K | 115,636 | D | ↗ |
| 2025-03-21 | Johnson Anne Nagengast | Officer | S-Sale | D | Common Shares | 33,545 | 1.35 | 45.3K | 140,045 | D | ↗ |
| 2025-03-21 | Craig Kevin James | Officer | S-Sale | D | Common Shares | 11,563 | 1.35 | 15.6K | 8,437 | D | ↗ |
| 2025-03-14 | Short Glenn Frank | Officer | M-Exempt | D | Restricted Stock Units | 32,500 | 0.00 | — | 0 | D | ↗ |
| 2025-03-14 | Rao Srinivas | Officer | M-Exempt | A | Common Shares | 175,000 | 0.00 | — | 288,360 | D | ↗ |
| 2025-03-14 | Kirpekar Sahil | Officer | M-Exempt | D | Common Shares | 100,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-14 | Johnson Anne Nagengast | Officer | M-Exempt | A | Common Shares | 100,000 | 0.00 | — | 173,590 | D | ↗ |
| 2025-03-14 | Craig Kevin James | Officer | M-Exempt | D | Restricted Stock Units | 20,000 | 0.00 | — | 0 | D | ↗ |
| 2025-03-03 | Short Glenn Frank | Officer | A-Award | A | Stock Option | 757,915 | 1.50 | 1.14M | 757,915 | D | ↗ |
| 2025-03-03 | Johnson Anne Nagengast | Officer | A-Award | A | Stock Option | 757,915 | 1.50 | 1.14M | 757,915 | D | ↗ |
| 2025-03-03 | Craig Kevin James | Officer | A-Award | A | Stock Option | 757,915 | 1.50 | 1.14M | 757,915 | D | ↗ |
| 2025-02-14 | Apeiron Investment Group Ltd. | 10% Owner | P-Purchase | A | Common Shares | 10,835,718 | 2.10 | 22.76M | 40,555,215 | I | ↗ |
| 2025-01-07 | Rao Srinivas | Officer | A-Award | A | Stock Option | 2,340,000 | 1.75 | 4.10M | 2,340,000 | D | ↗ |
| 2025-01-02 | Kochendoerfer Gerd | Officer | A-Award | A | Stock Option | 1,450,000 | 1.60 | 2.32M | 1,450,000 | D | ↗ |
| 2025-01-01 | Short Glenn Frank | Officer | — | — | Stock Option | 71,620 | 2.86 | 204.8K | 0 | D | ↗ |
| 2025-01-01 | Craig Kevin James | Officer | — | — | Stock Option | 388,000 | 1.84 | 713.9K | 0 | D | ↗ |
| 2024-12-03 | Kochendoerfer Gerd | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-10-04 | Rao Srinivas | Officer | D-Return | D | Stock Option | 709,952 | 11.71 | 8.31M | 0 | D | ↗ |
| 2024-10-04 | Johnson Anne Nagengast | Officer | D-Return | D | Stock Option | 326,416 | 5.68 | 1.85M | 0 | D | ↗ |
| 2024-10-04 | Brand Florian | Officer | A-Award | A | Stock Option | 338,112 | 11.71 | 3.96M | 338,112 | D | ↗ |
| 2024-10-04 | Angermayer Christian | Director / 10% Owner | D-Return | D | Stock Option | 624,000 | 5.68 | 3.54M | 0 | D | ↗ |
| 2024-06-13 | Smiley Andrea Heslin | Director | A-Award | A | Stock Option | 103,000 | 1.34 | 138.0K | 103,000 | — | ↗ |
| 2024-06-13 | Kalali Amir H | Director | A-Award | A | Stock Option | 103,000 | 1.34 | 138.0K | 103,000 | — | ↗ |
| 2024-06-13 | JOHNSON SABRINA MARTUCCI | Director | A-Award | A | Stock Option | 103,000 | 1.34 | 138.0K | 103,000 | — | ↗ |
| 2024-06-13 | Fischer Laurent | Director | A-Award | A | Stock Option | 206,000 | 1.34 | 276.0K | 206,000 | — | ↗ |
| 2024-06-13 | Braunstein Scott | Director | A-Award | A | Stock Option | 206,000 | 1.34 | 276.0K | 206,000 | — | ↗ |
| 2024-06-13 | Auerbach Michael | Director | A-Award | A | Stock Option | 103,000 | 1.34 | 138.0K | 103,000 | — | ↗ |
| 2024-06-13 | Angermayer Christian | Director / 10% Owner | A-Award | A | Stock Option | 103,000 | 1.34 | 138.0K | 103,000 | — | ↗ |
| 2024-05-31 | Fischer Laurent | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-31 | Braunstein Scott | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-16 | Brand Florian | Officer | S-Sale | D | Common Shares | 151,303 | 1.92 | 290.5K | 328,697 | — | ↗ |
| 2024-04-15 | Apeiron Investment Group Ltd. | 10% Owner | J-Other | A | Convertible Notes | 147,950 | 0.00 | — | 147,950 | — | ↗ |
| 2024-04-02 | Rao Srinivas | Officer | S-Sale | D | Common Shares | 61,640 | 1.85 | 114.0K | 113,360 | — | ↗ |
| 2024-04-02 | Kirpekar Sahil | Officer | S-Sale | D | Common Shares | 35,801 | 1.85 | 66.2K | 64,199 | — | ↗ |
| 2024-04-02 | Johnson Anne Nagengast | Officer | S-Sale | D | Common Shares | 27,410 | 1.85 | 50.7K | 73,590 | — | ↗ |
| 2024-03-14 | Rao Srinivas | Officer | M-Exempt | D | Restricted Stock Units | 175,000 | 0.00 | — | 175,000 | — | ↗ |
| 2024-03-14 | Kirpekar Sahil | Officer | M-Exempt | A | Common Shares | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2024-03-14 | Johnson Anne Nagengast | Officer | M-Exempt | A | Common Shares | 100,000 | 0.00 | — | 101,000 | — | ↗ |
| 2024-03-14 | Brand Florian | Officer | M-Exempt | D | Restricted Stock Unit | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2024-03-13 | Rao Srinivas | Officer | A-Award | A | Stock Option | 800,000 | 1.84 | 1.47M | 800,000 | — | ↗ |
| 2024-03-13 | Kirpekar Sahil | Officer | A-Award | A | Stock Option | 550,000 | 1.84 | 1.01M | 550,000 | — | ↗ |
| 2024-03-13 | Johnson Anne Nagengast | Officer | A-Award | A | Stock Option | 550,000 | 1.84 | 1.01M | 550,000 | — | ↗ |
| 2024-01-05 | Angermayer Christian | Director / 10% Owner | A-Award | A | Stock Option | 642,000 | 1.64 | 1.05M | 642,000 | — | ↗ |
| 2023-11-16 | Brand Florian | Officer | P-Purchase | A | Common Shares | 20,000 | 1.16 | 23.1K | 130,000 | — | ↗ |
| 2023-09-13 | Brand Florian | Officer | P-Purchase | A | Common Shares | 40,000 | 1.45 | 58.0K | 110,000 | — | ↗ |
| 2023-05-23 | Smiley Andrea Heslin | Director | A-Award | A | Stock Option | 64,000 | 1.88 | 120.3K | 64,000 | — | ↗ |
| 2023-05-23 | Kalali Amir H | Director | A-Award | A | Stock Option | 64,000 | 1.88 | 120.3K | 64,000 | — | ↗ |
| 2023-05-23 | JOHNSON SABRINA MARTUCCI | Director | A-Award | A | Stock Option | 64,000 | 1.88 | 120.3K | 64,000 | — | ↗ |
| 2023-05-23 | Camm Jason | Director | A-Award | A | Stock Option | 64,000 | 1.88 | 120.3K | 64,000 | — | ↗ |
| 2023-05-23 | Auerbach Michael | Director | A-Award | A | Stock Option | 64,000 | 1.88 | 120.3K | 64,000 | — | ↗ |
| 2023-05-23 | Angermayer Christian | Director / 10% Owner | A-Award | A | Stock Option | 64,000 | 1.88 | 120.3K | 64,000 | — | ↗ |
| 2023-05-10 | Johnson Anne Nagengast | Officer | — | D | Restricted Stock Unit | 200,000 | 0.00 | — | 0 | — | ↗ |
| 2023-03-29 | Brand Florian | Officer | P-Purchase | A | Common Shares | 70,000 | 1.48 | 103.6K | 70,000 | — | ↗ |
| 2023-03-29 | Apeiron Investment Group Ltd. | 10% Owner | P-Purchase | A | Common Shares | 1,214,297 | 1.32 | 1.60M | 32,086,697 | — | ↗ |
| 2023-03-14 | Rao Srinivas | Officer | A-Award | A | Restricted Stock Unit | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2023-03-14 | Kirpekar Sahil | Officer | A-Award | A | Restricted Stock Unit | 200,000 | 0.00 | — | 200,000 | — | ↗ |
| 2023-03-14 | Gutierrez-Esteinou Rolando | Officer | A-Award | A | Restricted Stock Unit | 200,000 | 0.00 | — | 200,000 | — | ↗ |
| 2023-03-14 | Brand Florian | Officer | A-Award | A | Restricted Stock Unit | 700,000 | 0.00 | — | 700,000 | — | ↗ |
| 2023-03-14 | Bardin Stephen | Officer | A-Award | A | Stock Option | 600,000 | 1.18 | 708.0K | 600,000 | — | ↗ |
| 2022-12-01 | Kirpekar Sahil | Officer | A-Award | A | Stock Option | 750,000 | 0.00 | — | 750,000 | — | ↗ |
| 2022-11-29 | Kirpekar Sahil | — | — | — | — | — | — | — | 0 | — | ↗ |
| 2022-08-16 | Bardin Stephen | Officer | — | D | Stock Option | 1,000,000 | 3.65 | 3.65M | 0 | — | ↗ |
| 2022-05-25 | de Rosnay Alexis | Director | A-Award | A | Stock Option | 64,000 | 0.00 | — | 64,000 | — | ↗ |
| 2022-05-25 | Smiley Andrea Heslin | Director | A-Award | A | Stock Option | 64,000 | 0.00 | — | 64,000 | — | ↗ |
| 2022-05-25 | Kalali Amir H | Director | A-Award | A | Stock Option | 64,000 | 0.00 | — | 64,000 | — | ↗ |
| 2022-05-25 | JOHNSON SABRINA MARTUCCI | Director | A-Award | A | Stock Option | 64,000 | 3.84 | 245.8K | 64,000 | — | ↗ |
| 2022-05-25 | Auerbach Michael | Director | A-Award | A | Stock Option | 64,000 | 0.00 | — | 64,000 | — | ↗ |
| 2022-05-25 | Angermayer Christian | Director | A-Award | A | Stock Option | 64,000 | 0.00 | — | 64,000 | — | ↗ |
| 2022-04-28 | Angermayer Christian | Director | P-Purchase | A | Common Shares | 21,900 | 4.47 | 97.8K | 1,799,302 | — | ↗ |
| 2022-04-26 | Angermayer Christian | Director | P-Purchase | A | Common Shares | 19,803 | 4.64 | 91.9K | 1,742,702 | — | ↗ |
| 2022-04-22 | Angermayer Christian | Director | P-Purchase | A | Common Shares | 52,820 | 4.83 | 255.0K | 1,667,731 | — | ↗ |
| 2022-04-20 | Angermayer Christian | Director | P-Purchase | A | Common Shares | 68,688 | 4.95 | 340.0K | 1,614,911 | — | ↗ |
| 2022-04-18 | Angermayer Christian | Director | P-Purchase | A | Common Shares | 54,322 | 5.11 | 277.7K | 1,413,205 | — | ↗ |
| 2022-04-14 | Angermayer Christian | Director | P-Purchase | A | Common Shares | 4,967 | 5.19 | 25.8K | 1,358,883 | — | ↗ |
| 2022-04-12 | Angermayer Christian | Director | P-Purchase | A | Common Shares | 55,197 | 4.88 | 269.6K | 1,353,916 | — | ↗ |
| 2022-04-08 | Angermayer Christian | Director | P-Purchase | A | Common Shares | 57,689 | 4.81 | 277.6K | 1,244,793 | — | ↗ |
| 2022-04-06 | Angermayer Christian | Director | P-Purchase | A | Call Option (right to purchase) | 1,000,000 | 0.96 | 959.8K | 1,000,000 | — | ↗ |
| 2022-03-02 | WEAVER GREGORY L | Officer | A-Award | A | Stock Option | 228,000 | 5.65 | 1.29M | 228,000 | — | ↗ |
| 2022-03-02 | Rao Srinivas | Officer | A-Award | A | Stock Option | 840,000 | 0.00 | — | 840,000 | — | ↗ |
| 2022-03-02 | Gutierrez-Esteinou Rolando | Officer | A-Award | A | Stock Option | 206,950 | 0.00 | — | 206,950 | — | ↗ |
| 2022-03-02 | Brand Florian | Officer | A-Award | A | Stock Option | 649,050 | 0.00 | — | 649,050 | — | ↗ |
| 2022-01-14 | Auerbach Michael | Director | J-Other | D | Common Shares | 5,559,808 | 0.00 | — | 0 | — | ↗ |
| 2021-12-24 | Gutierrez-Esteinou Rolando | Officer | A-Award | A | Stock Option | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-10 | de Rosnay Alexis | Director | A-Award | A | Stock Option | 128,000 | 16.46 | 2.11M | 128,000 | — | ↗ |
| 2021-09-10 | Smiley Andrea Heslin | Director | A-Award | A | Stock Option | 128,000 | 16.46 | 2.11M | 128,000 | — | ↗ |
| 2021-09-10 | Kalali Amir H | Director | A-Award | A | Stock Option | 128,000 | 16.46 | 2.11M | 128,000 | — | ↗ |
| 2021-09-10 | JOHNSON SABRINA MARTUCCI | Director | A-Award | A | Stock Option | 128,000 | 16.46 | 2.11M | 128,000 | — | ↗ |
| 2021-09-10 | Camm Jason | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-10 | Auerbach Michael | Director | A-Award | A | Stock Option | 128,000 | 16.46 | 2.11M | 128,000 | — | ↗ |
| 2021-09-10 | Angermayer Christian | Director / 10% Owner | A-Award | A | Stock Option | 128,000 | 16.46 | 2.11M | 128,000 | — | ↗ |
| 2021-06-22 | de Rosnay Alexis | Director | P-Purchase | A | Common Shares | 4,666 | 15.00 | 70.0K | 4,666 | — | ↗ |
| 2021-06-22 | WEAVER GREGORY L | Officer | P-Purchase | A | Common Shares | 4,666 | 15.00 | 70.0K | 4,666 | — | ↗ |
| 2021-06-22 | Smiley Andrea Heslin | Director | P-Purchase | A | Common Shares | 4,666 | 15.00 | 70.0K | 4,666 | — | ↗ |
| 2021-06-22 | Rao Srinivas | Officer | P-Purchase | A | Common Shares | 3,500 | 15.00 | 52.5K | 3,500 | — | ↗ |
| 2021-06-22 | Kalali Amir H | Director | P-Purchase | A | Common Shares | 4,666 | 15.00 | 70.0K | 4,666 | — | ↗ |
| 2021-06-22 | Brand Florian | Officer | P-Purchase | A | Common Shares | 2,333 | 15.00 | 35.0K | 2,333 | — | ↗ |
| 2021-06-22 | Auerbach Michael | Director | P-Purchase | A | Common Shares | 4,666 | 15.00 | 70.0K | 5,564,474 | — | ↗ |
| 2021-06-22 | Apeiron Investment Group Ltd. | 10% Owner | P-Purchase | A | Common Shares | 700,000 | 15.00 | 10.50M | 20,185,200 | — | ↗ |
| 2021-06-22 | Angermayer Christian | Director / 10% Owner | P-Purchase | A | Common Shares | 700,000 | 15.00 | 10.50M | 20,185,200 | — | ↗ |
| 2021-06-17 | de Rosnay Alexis | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-17 | WEAVER GREGORY L | Officer | — | D | Stock Option | 880,000 | 2.51 | 2.21M | 0 | — | ↗ |
| 2021-06-17 | Smiley Andrea Heslin | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-17 | Rao Srinivas | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-17 | Kalali Amir H | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-17 | JOHNSON SABRINA MARTUCCI | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-17 | Gutierrez-Esteinou Rolando | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-17 | Camm Jason | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-17 | Brand Florian | Officer | — | D | Stock Option | 4,800,000 | 0.38 | 1.82M | 0 | — | ↗ |
| 2021-06-17 | Auerbach Michael | Director | — | I | Common Shares | 0 | 0.00 | — | 5,559,808 | — | ↗ |
| 2021-06-17 | Apeiron Investment Group Ltd. | 10% Owner | — | I | Convertible Notes | 8,320,000 | 0.00 | — | 0 | — | ↗ |
| 2021-06-17 | Angermayer Christian | Director / 10% Owner | — | I | Common Shares | 0 | 0.00 | — | 19,485,200 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-66.5K
Shares Outstanding
188.63M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Srinivas Rao, M.D., Ph.D., Chief Executive Officer | 568.3K | 255.8K | — | 2.63M | — | 10.4K | 3.46M | 75.90% | ↗ |
| 2 | 2024 | Florian Brand, Former Chief Executive Officer | 550.0K | 247.5K | 599.5K | 1.97M | — | 4.9K | 3.38M | 76.23% | ↗ |
| 3 | 2024 | Anne Johnson, Chief Financial Officer | 415.0K | 149.5K | — | 927.3K | — | 10.4K | 1.50M | 61.73% | ↗ |
| 4 | 2024 | Sahil Kirpekar, M.D., Former Chief Business Officer | 455.0K | 163.8K | — | 792.2K | — | 10.4K | 1.42M | 55.73% | ↗ |
| 5 | 2023 | Florian Brand, Former Chief Executive Officer | 550.0K | 233.8K | 826.0K | 1.41M | — | 9.6K | 3.03M | 73.79% | ↗ |
| 6 | 2023 | Florian Brand, Chief Executive Officer | 550.0K | 233.8K | 826.0K | 1.41M | — | 9.6K | 3.03M | 73.79% | ↗ |
| 7 | 2023 | Srinivas Rao, M.D., Ph.D., Chief Executive Officer | 550.0K | 233.8K | 413.0K | 528.0K | — | 9.9K | 1.73M | 54.25% | ↗ |
| 8 | 2023 | Srinivas Rao, M.D., Ph.D., Chief Scientific Officer | 550.0K | 233.8K | 413.0K | 528.0K | — | 9.9K | 1.73M | 54.25% | ↗ |
| 9 | 2023 | Stephen Bardin Former Chief Financial Officer | 440.0K | 149.6K | 413.0K | 528.0K | — | 17.5K | 1.55M | 60.78% | ↗ |
| 10 | 2023 | Rolando Gutierrez-Esteinou, M.D. Former Chief Medical Officer | 330.0K | 118.0K | 236.0K | 440.0K | — | 349.4K | 1.47M | 45.88% | ↗ |
| 11 | 2023 | Anne Johnson Chief Financial Officer | 360.0K | 124.3K | 236.0K | 440.0K | — | 9.9K | 1.17M | 57.77% | ↗ |
| 12 | 2023 | Anne Johnson, Chief Financial Officer | 360.0K | 124.3K | 236.0K | 440.0K | — | 9.9K | 1.17M | 57.77% | ↗ |
| 13 | 2022 | Florian Brand, Chief Executive Officer | 550.0K | 275.0K | — | 3.42M | — | 10.4K | 4.26M | 80.37% | ↗ |
| 14 | 2022 | Srinivas Rao, M.D., Ph.D., Chief Scientific Officer | 550.0K | 275.0K | — | 2.74M | — | 9.2K | 3.57M | 76.64% | ↗ |
| 15 | 2022 | Stephen Bardin Former Chief Financial Officer | 226.7K | 190.7K | — | 2.28M | — | 19.8K | 2.72M | 83.91% | ↗ |
| 16 | 2022 | Stephen Bardin Chief Financial Officer | 226.7K | 190.7K | — | 2.28M | — | 19.8K | 2.72M | 83.91% | ↗ |
| 17 | 2021 | Florian Brand, Chief Executive Officer | 440.5K | 186.2K | 21.34M | 4.56M | — | 1.1K | 26.52M | 97.63% | ↗ |
| 18 | 2021 | Srinivas Rao, M.D., Ph.D., Chief Scientific Officer | 480.7K | 204.1K | — | 11.25M | — | 8.7K | 11.95M | 94.20% | ↗ |
| 19 | 2021 | Srinivas Rao, MD, PhD, Chief Scientific Officer | 480.7K | 204.1K | — | 11.25M | — | 8.7K | 11.95M | 94.20% | ↗ |
| 20 | 2021 | Rolando Gutiérrez-Esteinou, Chief Medical Officer | 420.0K | 195.4K | — | 10.75M | — | — | 11.37M | 94.59% | ↗ |
| 21 | 2020 | Florian Brand, Chief Executive Officer | 306.7K | — | — | 11.13M | 92.0K | 6.3K | 11.54M | 96.49% | ↗ |
| 22 | 2020 | Srinivas Rao, MD, PhD, Chief Scientific Officer | 400.0K | — | — | 2.94M | 120.0K | 15.0K | 3.48M | 84.62% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
| Filing date | Form type | Filing |
|---|---|---|
| 2025-10-16 | DEFA14A | ↗ |
| 2025-10-10 | DEFA14A | ↗ |
| 2025-09-29 | DEFA14A | ↗ |
| 2025-09-23 | DEFA14A | ↗ |
| 2025-08-14 | DEFA14A | ↗ |
| 2025-07-02 | DEFA14A | ↗ |
| 2025-07-02 | DEFA14A | ↗ |
| 2025-07-01 | DEFA14A | ↗ |
| 2025-06-18 | DEFA14A | ↗ |
| 2025-06-03 | DEFA14A | ↗ |
| 2025-06-02 | DEFA14A | ↗ |
| 2025-06-02 | DEFA14A | ↗ |
| 2025-06-02 | DEFA14A | ↗ |
| 2025-04-21 | DEF 14A | ↗ |
| 2025-04-11 | PRE 14A | ↗ |
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Srinivas G. Rao | Co-Founder, Chief Executive Officer & Executive Director | 1M | — |
| Ryan Barrett | Chief Legal & Business Officer | 709.7K | male |
| Gerd G. Kochendoerfer | Chief Operating Officer | 679.3K | — |
| Kevin Craig | Chief Medical Officer | 615.4K | — |
| Anne Johnson | Chief Accounting Officer | 574.8K | female |
| Michael Eric Faerm | Chief Financial Officer | 574.8K | male |
| Christian Angermayer | Co-Founder & Chairman of the Board | 75.0K | male |
| Jason Awe | Vice President of Investor Relations | — | — |
| Robert Conley | Chief Research & Development Officer | — | — |
| Glenn Short | Chief Scientific Officer | — | — |
| Kavita Panke | Senior Vice President of New Product, Planning & Commercial | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ATAI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
